SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Sientra, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of November 24, 2015 -- SIEN


NEW YORK, Oct. 2, 2015 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired securities of Sientra, Inc. ("Sientra") (NASDAQ:SIEN) between March 18, 2015 and September 24, 2015.

You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Central District of California. If you purchased or otherwise acquired Sientra securities between March 18, 2015 and September 24, 2015, your rights may be affected by this action. To get more information go to:

http://zlk.9nl.com/sientra

or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The complaint alleges that defendants failed to disclose that Sientra's exclusive reliance on Silimed's Brazilian manufacturing facilities carried significant quality control risks and that the manufacturing processes at the Silimed Rio de Janeiro manufacturing plant were contaminated. On March 18, 2015, Sientra filed its Form 10-K with the U.S. Securities and Exchange Commission, which stated that it was primarily responsible for the manufacturing and quality assurance of its products.

On September 24, 2015, the United Kingdom's Medicines and Healthcare Products Regulatory Agency suspended sales of Silimed products after an audit of Silimed's manufacturing processes revealed contamination in the manufacturing plant. On this news, Sientra stock fell $10.88, or nearly 52.9%, to close at $9.70 per share on September 24, 2015.

If you suffered a loss in Sientra you have until November 24, 2015 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.



            

Contact Data